Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load
Main Author: | |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2021-04-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.04.009 |
id |
doaj-ca016c6d30fb484e9f77799a5a3fbbc9 |
---|---|
record_format |
Article |
spelling |
doaj-ca016c6d30fb484e9f77799a5a3fbbc92021-04-26T08:13:42ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562021-04-01374778780Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral loadLIN Bingliang0The Third Affiliated Hospital of Sun Yat-Sen Universityhttp://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.04.009 |
collection |
DOAJ |
language |
zho |
format |
Article |
sources |
DOAJ |
author |
LIN Bingliang |
spellingShingle |
LIN Bingliang Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load Linchuang Gandanbing Zazhi |
author_facet |
LIN Bingliang |
author_sort |
LIN Bingliang |
title |
Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load |
title_short |
Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load |
title_full |
Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load |
title_fullStr |
Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load |
title_full_unstemmed |
Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load |
title_sort |
patients in the immune-tolerant phase of hepatitis b virus infection should receive antiviral therapy to reduce viral load |
publisher |
Editorial Department of Journal of Clinical Hepatology |
series |
Linchuang Gandanbing Zazhi |
issn |
1001-5256 1001-5256 |
publishDate |
2021-04-01 |
url |
http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.04.009 |
work_keys_str_mv |
AT linbingliang patientsintheimmunetolerantphaseofhepatitisbvirusinfectionshouldreceiveantiviraltherapytoreduceviralload |
_version_ |
1721507736677515264 |